CD10—also referred to as the acute lymphoblastic leukemia antigen—is a neutral endopeptidase located on the cell surface that inactivates biologically active peptides and may represent a molecular marker that correlates with the prognosis of ESS patients [55]. The gene discussed is MME; the disease is leukemia.